Results from GSEA showed that XPO1 activated KEGG Pathways in cancer, KEGG_Ubiquitin mediated proteolysis, KEGG_Cell cycle, KEGG_Spliceosome, and KEGG_Chronic myeloid leukemia (Figure 2E). This evidence concerns the gene XPO1 and chronic myelogenous leukemia, BCR-ABL1 positive.